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Abstract 
Virtual reality exposure (VRE) has been shown to be effective for treating a variety of anxiety 
disorders, including social phobia.  Presence, or the level of connection an individual feels with 
the virtual environment, is widely discussed as a critical construct both for the experience of 
anxiety within a virtual environment and for a successful response to VRE. Two published 
studies show that whereas generalized presence relates to fear ratings during VRE, it does not 
relate to treatment response. However, presence has been conceptualized as multidimensional, 
with three primary factors (spatial presence, involvement, and realness). These factors can be 
linked to other research on the facilitation of fear during exposure, inhibitors of treatment 
response (e.g., distraction), and more recent theoretical discussions of the mechanisms of 
exposure therapy, such as Bouton’s (2004) description of expectancy violation. As such, one or 
more of these components of presence may be more strongly associated with the experience of 
fear during VRE and treatment response than the overarching construct. The current study 
(N=41) evaluated relations between three theorized components of presence, fear ratings during 
VRE, and treatment response for VRE for social phobia.  Results suggest that total presence and 
realness subscale scores were related to in-session peak fear ratings.  However, only scores on 
the involvement subscale significantly predicted treatment response.  Implications of these 
findings are discussed.  
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Does engagement with exposure yield better outcomes?: Components of presence as a predictor 
of treatment response for virtual reality exposure therapy for social phobia 
1. Introduction  
Virtual Reality Exposure Therapy (VRE) is an effective treatment for a variety of anxiety 
disorders, including social phobia (for a review see Parsons & Rizzo, 2008). VRE involves 
exposing anxious individuals to virtually-generated feared stimuli. An advantage of VRE relative 
to in vivo exposure therapies is the greater ease with which therapists can manipulate the feared 
stimuli within the virtual environment (Rothbaum, Hodges, Kooper, & Opdyke, 1995).  This 
advantage is especially relevant to exposure treatment for social phobia, because in vivo 
treatment of social fears (e.g., fear of public speaking) requires recruitment of potentially large 
numbers of “audience members” on multiple occasions. Simulation of public speaking scenarios 
using virtual environments thus circumvents a significant barrier to treatment (Olfson et al., 
2000).  
A handful of studies have demonstrated the utility of VRE for reducing symptoms among 
those diagnosed with social phobia and those with high levels of public speaking fears.  The 
largest study to date examined changes in social fears after 12 sessions of VRE in 18 participants 
with social phobia (Klinger et al., 2005). Exposures were conducted in four virtual environments; 
these environments replicated different social situations that revolved around performance (e.g., 
public speaking), interpersonal interaction (e.g., a dinner conversation), assertiveness (e.g., 
having a viewpoint challenged), and evaluation (e.g., completing a task while being observed).  
Those who received individual VRE demonstrated a comparable decrease in symptoms to those 
receiving cognitive behavioral group therapy.  Two trials with smaller samples yielded similar 
findings. Anderson and colleagues (2005) demonstrated that VRE reduced public speaking fears 
Presence and Treatment Outcome 4 
in 10 participants diagnosed with social phobia. VRE also was more effective than no treatment 
at reducing public speaking fears in a sample of undergraduates that rated public speaking as a 
highly feared situation (Harris, Kemmerling, & North, 2002).   
The concept of presence has been identified as a mechanism by which exposure to virtual 
stimuli can successfully treat fears in the real world (Parsons & Rizzo, 2008; Regenbrecht, 
Schubert, & Friedmann, 1998; Robillard, Bouchard, Fournier, & Renaud, 2003; Rothbaum et al., 
1995; Wiederhold & Wiederhold, 2005).  Presence is the extent to which an individual feels 
connected to or engaged with a virtual stimulus or environment (Lee, 2004; Schubert, 
Friedmann, & Regenbrecht, 2001).  Empirical investigations and theoretical models both suggest 
that presence is comprised of multiple factors (Lee, 2004; Schubert et al., 2001; Witmer & 
Singer, 1998). The first factor, spatial presence, is the feeling that one is physically in the virtual 
space.  Involvement, the second factor, is the extent to which one keeps attention focused on the 
virtual stimulus and ignores competing incongruent information.  Realness, or the extent that the 
virtual stimulus coincides with expectations of the real stimulus, constitutes the third factor.  
Despite the theorized relation between presence and VRE treatment response, there has 
been relatively little research on this topic, and results have been underwhelming. Specifically, 
two published empirical studies in this area found no significant relations between presence and 
response to VRE treatment for specific phobias (Krijn et al., 2004; Price & Anderson, 2007).  
Krijn and colleagues (2004) compared treatment response for acrophobia across high- and low-
presence conditions.  Researchers manipulated presence by using a complex computer-
automated virtual environment (CAVE) which projects the virtual environment on the walls of a 
room for the high presence condition and a head mounted display (HMD) for the low presence 
condition. Results indicated that treatment response did not differ across high- and low-presence 
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conditions.  Price and Anderson (2007) reported similar findings in a sample of adults who 
received 8 sessions of VRE for fear of flying. Although presence was associated with peak fear 
ratings during the first virtual reality exposure therapy session, it did not predict treatment 
response.  
These null findings as to the relation between presence and treatment response challenge a 
basic assumption of VRE – that presence is a mechanism by which exposure therapy works.  
From the beginning, VRE researchers linked the concept of presence to the emotion processing 
theory (Foa & Kozak, 1986), which posits that a phobic fear structure must be activated through 
presentation of a feared stimulus in order for effective exposure therapy to occur.  Presence was 
conceptualized as the construct that enabled the experience of fear towards a virtual stimulus; it 
thus constituted a necessary condition for effective exposure therapy as detailed by emotional 
processing theory (Anderson, Rothbaum, & Hodges, 2000).  Indeed, the first VRE treatment 
outcome studies specifically targeted fears with powerful physical cues (e.g., height) that could 
be easily modeled within a virtual environment in order to maximize presence and fear structure 
activation (Rothbaum et al., 1995).  
However, according to emotional processing theory, activation of the fear structure alone 
does not guarantee effective exposure therapy (Foa & Kozak, 1986). According to the emotion 
processing theory, effective exposure therapy requires prolonged, repeated, and controlled 
exposure to feared stimuli for extinction of fear to occur.  Although VRE is described as an ideal 
mechanism for exposure therapy because it can be more easily manipulated (e.g., prolonged, 
repeated, and controlled) than in vivo exposure, it is still a context that provides only the 
potential for extinction learning.  As a result, presence has been described as a construct that is 
necessary, but not sufficient for obtaining treatment response (Price & Anderson, 2007).   
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Examining the distinct factors that compose the construct of “presence” may help clarify 
both its potential relation to VRE treatment response and the null findings to date obtained with 
global presence measures.  For example, the involvement factor reflects attention to the virtual 
stimulus, and relates to research showing that distraction from feared stimuli inhibits treatment 
response (Grayson, Foa, & Steketee, 1982; Wells & Papageorgiou, 1998). Presumably, greater 
involvement with the virtual environment is associated with greater attention to the feared 
stimulus, thus enhancing the effectiveness of the virtual environment as a context for extinction 
learning.  
The realness factor of presence (the extent to which the virtual stimulus coincides with 
expectations about the real world stimulus), maps on to the face valid concept of how “real” the 
virtual environment feels, and may be important for fear structure activation. It also pertains to 
Bouton’s (2004) notion of the importance of expectancy violation in extinction learning. 
According to Bouton, exposure therapy provides the opportunity for disconfirmation of 
expectations about feared stimuli (e.g., when a college student with social phobia signs up for a 
class that includes an oral presentation and finds that she neither fails the assignment nor is 
humiliated, and the experience disconfirms her negative expectations). In the context of VRE, 
the notion of expectancy violation is particularly interesting. There are likely some expectancies 
that cannot be violated in the virtual environment (e.g., there is no chance that the student will 
fail a course based on poor performance on a speech in a virtual environment) and other 
expectancies that could be violated (e.g., the person does not sound “stupid” while speaking to a 
group).  
Finally, the spatial presence factor of presence (the extent that the participant feels they are 
physically in the virtual environment) has been associated with increased physiological arousal 
Presence and Treatment Outcome 7 
after completing goals in an interactive virtual environment (Niklas et al., 2004).  For those with 
social phobia, interacting with a virtual audience should lead to increased arousal and anxiety.  
Of the two prior studies that examined the relation between presence and treatment 
response, one study (Price & Anderson, 2007) assessed presence using a unidimensional 
measure, and thus did not assess the roles of distinct aspects of the construct. Krijn and 
colleagues (2004) did not assess presence directly, but instead manipulated it by assigning 
participants to low and high-presence conditions. Notably, a moderate proportion of participants 
dropped out or withdrew (n=10) from the low presence condition because it did not arouse 
anxiety. Thus, there are theoretical reasons to evaluate the relation between presence, particularly 
the factors of presence, and treatment response that have not been adequately examined in the 
two studies examining the topic to date.  
The current study sought to examine associations between presence, the global construct as 
well as its constituent factors (spatial presence, involvement, realness), fear ratings during VRE 
for public speaking fears, and treatment response among a clinical sample diagnosed with social 
phobia.  We hypothesized that the overall score on a self-report measure of presence, as well as 
scores on each of the 3 factor subscales would be positively associated with both fear ratings 
during VRE sessions and treatment response. A second aim of the study was to replicate prior 
research showing that the global construct of presence is related to fear ratings during VRE, and 
to extend this research by examining how specific presence factors relate to fear during VRE.  
2. Methods 
2.1 Participants 
Participants were 41 individuals diagnosed with social phobia according to DSM-IV 
criteria who were recruited as part of two larger treatment outcome studies. Diagnoses were 
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made using the Structured Clinical Interview for the DSM-IV (SCID; First, Gibbon, Spitzer, & 
Williams, 2002) by doctoral students that were trained in diagnostic interviewing via training 
tapes and practice interviews under the supervision of a licensed clinical psychologist. 
Agreement between the clinicians and the trainees on a subsample (20%) of the assessment 
interviews was 100%. Approximately 41% (n = 17) met criteria for social phobia: generalized 
subtype.  The majority of participants did not meet criteria for any comorbid diagnoses (n = 30, 
73%).  Participants were recruited through newspaper advertisements, posted flyers, and internet-
based outlets seeking participants with significant fears of public speaking.  To be included in the 
study, participants had to be English speakers and to meet DSM-IV criteria for social phobia. 
Participants taking psychoactive medication had to have been stabilized on their current 
medication(s) and dosage(s) for at least 3 months and were also required to remain at the same 
dosage throughout the study. Individuals meeting any of the following criteria were excluded, (a) 
history of mania, schizophrenia, or other psychoses; (b) current suicidal ideation; (c) current 
alcohol or substance dependence; (d) inability to tolerate the virtual reality helmet; (e) history of 
seizures.  
The majority of the sample was female (n = 24, 60%), married (n =19, 48%), and well 
educated (n = 27, 68%).  The sample self-identified as “Caucasian” (n = 21, 54%), “African-
American” (n =12, 28%), “Latino” (n = 2, 4%), and “Asian American” (n = 2, 6%). The 
remaining 3 participants reported “other” racial/ethnic identities.  
2.2. Measures 
The following measures were used to assess social phobia symptoms and presence.  
2.2.1 Igroup Presence Questionnaire (IPQ; Schubert et al., 2001): The IPQ is a 14-item self-
report questionnaire designed to assess presence. Items are scored on a 7-point likert scale (1-7) 
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with higher scores indicating a greater sense of presence. The IPQ can be used as a composite 
measure of presence with scores ranging from 7 to 98 or it can be divided into subscales 
assessing the three components of presence (spatial presence, involvement, and realness).  The 
spatial presence scale contains five items assessing feelings that one is physically within a virtual 
environment (e.g., “I had a sense of acting in the virtual space, rather than operating something 
from outside.”). The involvement subscale contains four items assessing attention to the virtual 
world (e.g., “I was completely captivated by the virtual world.”). The realness subscale contains 
four items assessing how real the virtual stimuli appear (e.g., “How real did the virtual world 
seem to you?”).  The measure has good psychometric properties and a factor structure that has 
been replicated across multiple samples (Schubert et al., 2001).  In the current study, the IPQ was 
administered at the end of sessions in which exposure was conducted (session 5 to 8).  
2.2.2 Personal Report of Confidence as a Speaker (PRCS; Paul, 1966): The PRCS is a 30-item 
self-report questionnaire that assesses behavioral and cognitive responses to public speaking.  
Sample items include “My hands tremble when I try to handle objects on the platform” and 
“While preparing a speech, I am in a constant state of anxiety.” Answers are recorded in a 
True/False format with summary scores ranging from 0-30 such that higher scores indicate 
greater fear of public speaking. The PRCS has been shown to be moderately to strongly 
correlated with broader measures of social phobia (Daly, 1978). Prior research with a large 
normative sample indicated that PRCS scores do not differ across demographic variables 
including age, ethnicity, and gender (Phillips, Jones, Rieger, & Snell, 1997).  Additionally, 
research that has used the PRCS as an outcome measure has shown it be sensitive to change for 
exposure based interventions (Altmaier, Ross, Leary, & Thornbrough, 1982; Kirsch & Henry, 
1977; Lawm, Schwartz, Houlihan, & Cassisi, 1994).  
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2.2.3 Subjective Unit of Discomfort Scale (SUDS): The SUDS rating scale is a self-report 
measurement of anxiety on a 0 to 100 point scale. Scores of 0 represent no fear and 100 
represents the most fear the individual has ever felt. The therapist recorded peak SUDS ratings 
during each virtual reality exposure treatment session.  
2.2.4 Structured Clinical Interview for the DSM-IV  (SCID; First et al., 2002): The SCID is a 
structured, well-validated diagnostic clinical interview used to assess psychological disorders 
based upon DSM-IV criteria. For the current project, the SCID was used to determine 
participation eligibility as well as presence of a variety of Axis I conditions within the mood, 
alcohol/substance use, and anxiety disorders modules.  
2.3 Procedure 
Data for the present study were collected through two treatment trials for a total of N = 
41. The first, a randomized controlled trial, compared cognitive behavioral group therapy to VRE 
to a WL control for social phobia. Only data from the participants who received VRE are 
included in the present study (n=31). The second trial (n=10) examined amygdala activity as a 
predictor of treatment response to VRE using functional magnetic resonance imaging (fMRI). 
For the purposes of the present study, the procedures are the same across the two trials, with the 
exception that participants in the fMRI trial were not randomly assigned to treatment; they all 
received VRE.  Figures 1 and 2 were prepared in accordance with guidelines outlined in the 
CONSORT (Consolidated Standards of Reporting Trials; Altman et al., 2001) and TREND 
(Transparent Reporting of Evaluations with Nonrandomized Designs; Des Jarlais, Lyles, Crepaz, 
& the TREND Group, 2004) statements. Figure 1 and Figure 2 show the flow of VRE 
participants through Trial 1 and Trial 2. 
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Setting and Personnel. All procedures for this study were conducted at the Psychology 
Clinic at Georgia State University and were approved by the University’s Institutional Review 
Board. Four doctoral candidates in clinical psychology conducted all assessment procedures, 
including telephone screening and in-person assessments under the supervision of a licensed 
clinical psychologist. Treatment was administered by five study therapists, two senior therapists 
were licensed psychologists with prior experience implementing manualized cognitive behavior 
therapy and three junior therapists were doctoral students. Prior to administering therapy, study 
therapists attended two-day intense training workshops, led by the developer of the treatment. 
Junior therapists were supervised by the last author.  
2.3.1 Assessments. Eligibility was determined through a two-part process, involving a 
brief telephone screening and an in-person, pre-treatment assessment. During the phone screen, 
potential participants were asked questions to rule out obvious exclusion criteria (e.g., began 
psychoactive medication within the past 3 months). Following the phone screen, interested and 
eligible individuals were scheduled for face-to-face pre-treatment assessment, which included 
administration of the SCID and self-report measures. Participants completed the PRCS at pre-
treatment, mid-treatment, and post-treatment assessments. The IPQ was administered at the end 
of each exposure session (sessions 5-8).   
2.3.2 Treatment. VRE consisted of eight sessions of individual therapy delivered 
according to a treatment manual (Anderson et al., 2005). The treatment was designed to target 
several processes shown to maintain social anxiety, including self-focused attention, negative 
perceptions of self and others, perceptions of lack of emotional control, rumination, and realistic 
goal setting for social situations. The first four sessions targeted these processes via use of 
cognitive restructuring and videotape feedback exercises, but did not include exposures to any of 
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the virtual environments. Sessions 5-8 consisted of exposure to various virtual environments.  
These scenarios were presented via a head-mounted display (HMD) that consisted of a helmet 
with headphones, goggles, and a tracker that allowed the virtual environment to move naturally 
with the participant. The virtual reality (VR) scenarios included 1) a conference room 
(approximately 5 audience members), 2) a classroom (approximately 35 audience members), and 
3) a large auditorium (approximately 100 audience members).  VRE therapists could manipulate 
audience reactions (e.g., making them appear interested/bored, supportive/hostile, distracted), as 
well the difficulty of questions posed by audience members, according to each client’s treatment 
goals.   
3. Results 
 Descriptive statistics for all variables can be found in Table 1. A preliminary comparison 
suggested that pretreatment PRCS scores did not significantly differ across participants with 
social phobia and those with social phobia: generalized subtype, F (1, 39) = 0.15, p = 0.70.  
3.1. The relation between presence and anxiety. 
 Multilevel modeling (MLM) was used to examine how strongly IPQ scores related to the 
experience of anxiety in session, as indicated by peak SUDS fear ratings. First, a model was 
fitted that included level 1 fixed effects for intercept, slope, and IPQ scores (Table 2). The fixed 
effect for slope was not significant, indicating that peak levels of fear did not change during the 
course of treatment (β10 = 0.12, p = 0.44), but the fixed effect for IPQ scores was significant (β  20 
= 0.09, p < 0.01).  This suggests that, after controlling for slope, overall presence was positively 
associated with peak fear ratings. To further explore the relation between presence and in-session 
fear, a similar model was constructed that included fixed effects for the IPQ subscales (spatial 
presence, involvement, and realness) instead of the total score.  These findings indicated that 
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after controlling for slope, realness was significantly related to peak fear ratings (β40 = 0.22, p < 
0.01), but spatial presence (β20 = 0.02, p = 0.84) and involvement (β30 = 0.01, p = 0.81) were not.  
3.2. Associations between presence and treatment response.  
 A repeated measures ANOVA was conducted to compare IPQ scores across exposure 
therapy sessions. Findings indicated that IPQ scores did not differ over time, F (3, 37) = 1.07, p 
= 0.37. Similar findings were obtained for the spatial presence, F (3, 37) = 2.11, p = 0.68, 
involvement, F (3, 37) = 2.48, p = 0.21, and realness subscales, F (3, 37) = 0.08, p = 0.97.  Based 
on these findings, mean IPQ and the IPQ subscale scores from the four sessions in which 
exposure was conducted were used to examine the association between presence and treatment 
response.  
A multilevel model that included a fixed effect for intercept and slope at level 1 and total 
IPQ scores at level 2 was fitted to examine how strongly presence predicted the rate of change 
during the course of treatment (Table 3). These findings suggested that PRCS scores declined 
during the course of treatment (β10 = -3.79, p < 0.01).  However, total IPQ scores were unrelated 
to the rate of change (β11 = -0.07, p = 0.16).   
 A similar model was used to examine the association between the IPQ subscales and 
treatment response (Table 3).  The subscales were entered as level 2 fixed effects for slope of 
PRCS scores. Findings indicated that the involvement scale was associated with an increased rate 
of change (slope; β12 = -0.40, p < 0.01), but the spatial presence (β11 = 0.20, p = 0.24) and 
realness scales were not (β13 = 0.14, p = 0.46).  The involvement scale alone accounted for 9% 
of the variance in the slope of PRCS scores. These findings indicate that the involvement 
component of presence related to changes in social phobia symptoms from pretreatment to 
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posttreatment but the overall construct of presence, as well as the spatial presence and realness 
components, were not.   
4. Discussion 
 Findings from the current study suggest that different components of presence are 
associated with the experience of fear and treatment response to VRE.  Total presence scores 
were significantly associated with peak self-reported fear ratings during VRE; however, this 
association appeared to be driven largely by a significant relationship between the realness 
component of presence and fear ratings during exposure. In contrast, the involvement scale was 
the only component that was significantly associated with treatment response.  
Findings that peak within session fear ratings were associated with the overall construct 
of presence and the realness subscale are consistent with prior research demonstrating a positive 
association between presence and anxiety towards virtual stimuli (Krijn, Emmelkamp, Olafsson, 
& Biemond, 2004; Price & Anderson, 2007).  Emotional processing theory indicates that a 
stimulus must be able to activate the fear structure if successful extinction learning is to take 
place (Foa & Kozak, 1986). The association found in this and prior studies suggest that presence 
is the mechanism by which a virtual stimulus can elicit fear and allow extinction learning to 
occur. Given the correlational nature of the present study, as well as the use of retrospective 
reports taken at the end of each session to measure presence, conclusions about the direction of 
this relation cannot be drawn.  It is possible that proneness to experience presence, particularly 
its realness component, leads to higher ratings of fear during exposure therapy.  Alternatively, 
elevated levels of fear during exposure may lead participants to report later that they felt more 
connected with the virtual environment and that it appeared more realistic. Additional research 
using “on-line” measures of presence during actual exposure sessions are necessary to better 
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understand how presence and fear relate to each other during VRE at both temporal and 
conceptual levels.   
 With regard to the relation between presence and treatment response, only scores on the 
involvement scale predicted response to VRE treatment for public speaking fear. The 
involvement subscale provides a measure of how closely the participant focused on the virtual 
environment and ignored distracting information from other sources during exposure (Schubert 
et al., 2001). Findings of the current study are consistent with other research demonstrating that 
sustained attention during exposure is associated with improved response, and distraction is 
associated with poorer response (Kamphuis & Telch, 2000; Telch et al., 2004), as well as work 
showing that an avoidant attention bias at the start of treatment was associated with reduced 
outcomes in those with social phobia (Price, Tone, & Anderson, In press). These findings were 
presumed to be attributed to the reduced availability of cognitive resources for extinction 
learning because of distraction.  Although not directly tested, the same explanation could apply 
to the current study. During VRE, participants reporting higher involvement were better able to 
focus on the virtual environment and ignore incongruent information from outside the virtual 
environment. Such individuals may therefore have been less likely to have divided attentional 
resources, leaving them with more attentional capacity to devote to extinction learning.  
These findings have implications for clinical work.  Clinicians using VRE to treat social 
phobia should try to maximize a client’s presence within the virtual environment. Past research 
has highlighted the importance of contextual cues in the acquisition of extinction learning 
(Bouton, 2004; Bouton, Westbrook, Corcoran, & Maren, 2006). VRE provides an excellent 
means to expose the participant to multiple contexts without leaving the therapist’s office. 
Results from the current study suggest that maximizing presence for each context may increase 
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the amount of fear experienced and maximizing involvement, or attentional focus, may lead to 
better treatment response.  At a practical level, this suggests that VRE therapists may achieve 
better results by turning off lights in the office to reduce distraction from outside the virtual 
environment. Prior research has shown that increasing the number of phobic elements, or salient 
aspects of feared stimuli, in virtual environments is associated with increased reports of presence 
(Price & Anderson, 2007; Ravaja et al., 2006). Asking clients to dress as they would when giving 
a presentation or to hold common presentation props such as pointers may be helpful in 
enhancing the VRE experience. Also, feared aspects that are specific to each client should be 
replicated during the exposures to enhance a sense of presence.  
Scores on the spatial presence subscale showed consistently nonsignificant associations 
with in-session fear and treatment response.  This suggests that spatial presence, the sense of 
being in the virtual world, may be less important for both the experience of and successful 
response to VRE than other components of presence.  Alternatively, because public speaking 
scenarios, which place the participant at the front of the audience as a speaker, were the only 
virtual environment used in the present study, it is possible that the implied physical distance 
between the participant and the audience members may have reduced participants’ feeling that 
they were physically present in an actual room.  Furthermore, public speaking scenarios typically 
involve less interaction with virtual audience members than do other types of social interaction 
scenarios, such as conversations. Thus, the implied physical distance from audience members 
may have attenuated associations between spatial presence and both the experience of fear, and 
treatment response.  Additional research is needed to assess the association between these 
variables in virtual environments (e.g., conversations or parties) that place participants in close 
proximity and sustained interactions with virtual peers.   
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The current study contained several limitations of note.  First, the study relied exclusively 
on self-report measures of public speaking fear and presence. Future work should assess how 
presence is associated with physiological indicators of public speaking fear such as skin 
conductance levels and heart rate.  Also, sample size for the current study was relatively small (N 
= 41). Although this is the largest sample of individuals with social phobia to receive VRE in the 
literature thus far, the inconsistency of the present findings with prior research in samples with 
specific phobia highlights the need for replication with larger samples before firm conclusions 
can be drawn about presence and treatment response. Third, the current study exclusively used 
public speaking scenarios, which constitute only one specific type of social interaction.  As a 
result, we do not know the effects of presence on decreases in fears for other social situations.  
This is important because a recent review (Blöte, Kint, Miers, & Westenberg, 2009) questioned 
the utility of speech tasks for assessing social anxiety symptoms, and suggested that public 
speaking anxiety may be a specific subtype of social phobia.  Additional research is needed to 
determine how these subscales may be associated with treatment response for other types of 
social interactions such as conversations, social settings such as parties, or other types of 
evaluative environments, as much of the research using VRE to treat social phobia has focused 
on addressing public speaking fears (Anderson et al., 2005; Harris et al., 2002; Klinger et al., 
2005). Virtual reality provides an excellent method by which to treat a variety of social fears due 
to the flexibility of the system in that it can portray a range of environments. The therapist can 
access a number of different social environments and interaction types to better tailor the 
exposure to the needs of the individual.   
 Despite these limitations, findings of the current study are consistent with prior research 
demonstrating that presence, particularly its realness component, is associated with the 
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experience of fear during VRE. It is the first study to show that presence (or any aspect of 
presence) is related to treatment response. The finding that a particular aspect of presence, 
involvement, is associated with treatment response converges with proposed mechanisms of 
exposure therapy.    
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Presence and Treatment Outcome 1 
Table 1. 
Descriptive statistics for presence and social phobia measures.  
  Pretreatment 
Midtreatment 
(Session 5) Session 6 Session 7 
Posttreatment 
(Session 8) 
PRCS 23.98 (3.11) 22.69 (4.35) - - 16.42 (7.26) 
IPQ - 56.77 (9.80) 57.16 (11.13) 57.44 (11.22) 55.38 (13.98) 
Spatial Presence - 20.33 (3.04) 20.54 (3.02) 20.11 (2.23) 20.73 (3.33) 
Involvement - 16.39 (4.37) 17.38 (5.58) 18.04 (5.21) 16.12 (6.22) 
Realness - 15.17 (4.59) 14.81 (4.76) 14.68 (5.00) 13.88 (5.98) 
Note: PRCS = Personal Report of Confidence as a Speaker. IPQ = Igroup Presence 
Questionnaire. Values in parentheses are standard deviations.
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Table 2. 
 
MLM using IPQ and IPQ subscales as a predictor of slope for peak SUDS ratings across session 
5 through 8. 
 Parameter SUDS 
Level 1    
Intercept β00i 1.59 (1.57) 
Slope β10i -0.12 (0.15) 
IPQ Total Score β20i 0.09** (0.02) 
Level 1    
Intercept β00i 2.65 (2.08) 
Slope β10i -0.10 (0.15) 
IPQ Spatial subscale β20i 0.02 (0.10) 
IPQ Involvement subscale β30i 0.01 (0.05) 
IPQ Realness subscale β40i 0.22** (0.05) 
 
Note: ** = p < 0.01. PRCS = Personal Report of Confidence as a Speaker. IPQ = Igroup 
Presence Questionnaire. Values in parentheses are standard errors.  
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Table 3. 
 
MLM using mean IPQ and mean IPQ subscales as a predictor of slope for PRCS 
 Parameter PRCS 
Level 1    
Intercept β00i 38.88** (1.14) 
Slope β10i -3.79** (0.55) 
Level 2   
IPQ Total Score β11i -0.07 (0.05) 
Level 1    
Intercept β00i 25.68** (0.56) 
Slope β10i -4.18** (0.57) 
Level 2   
IPQ Spatial subscale β11i 0.20 (0.16) 
IPQ Involvement subscale β12i -0.40** (0.13) 
IPQ Realness subscale β13i 0.13 (0.18) 
 
Note: ** = p < 0.01. PRCS = Personal Report of Confidence as a Speaker. IPQ = Igroup 
Presence Questionnaire. Values in parentheses are standard errors. 
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Figure 1. Flow of participants through Study 1, RCT.  
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Figure 2. Flow of participants through Study 2, fMRI clinical trial.  
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Figure 3. Treatment response for PRCS at +/- 1 standard deviation of the involvement subscale 
of the IPQ.  
 
